Relevant bibliographies by topics / Diagnosis related groups

Academic literature on the topic 'Diagnosis related groups'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Diagnosis related groups.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Diagnosis related groups"

1

Gibbs, Cedric C. J. "Diagnosis related groups." Medical Journal of Australia 143, no. 6 (September 1985): 227. http://dx.doi.org/10.5694/j.1326-5377.1985.tb122949.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tonkin, David. "Diagnosis related groups." Medical Journal of Australia 143, no. 6 (September 1985): 261. http://dx.doi.org/10.5694/j.1326-5377.1985.tb122972.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Last, Peter M. "Diagnosis related groups." Medical Journal of Australia 145, no. 10 (November 1986): 551. http://dx.doi.org/10.5694/j.1326-5377.1986.tb139485.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

DUCKETT, S. J. "Diagnosis related groups." Journal of Paediatrics and Child Health 29, no. 4 (August 1993): 263. http://dx.doi.org/10.1111/j.1440-1754.1993.tb00507.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Safran, Charles, Douglas Porter, Warner V. Slack, and Howard L. Bleich. "Diagnosis-Related Groups." Medical Care 25, no. 10 (October 1987): 1011–14. http://dx.doi.org/10.1097/00005650-198710000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mang, H., U. Kunzmann, and M. Bauer. "Diagnosis Related Groups." Der Anaesthesist 56, no. 9 (August 19, 2007): 867–76. http://dx.doi.org/10.1007/s00101-007-1255-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Michel, A., and E. O. Martin. "Diagnosis Related Groups." Der Anaesthesist 56, no. 9 (August 19, 2007): 865. http://dx.doi.org/10.1007/s00101-007-1257-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Greenberg, Larrie W. "Diagnosis-Related Groups." American Journal of Diseases of Children 139, no. 5 (May 1, 1985): 524. http://dx.doi.org/10.1001/archpedi.1985.02140070098046.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rivany, Ronnie. "Indonesia Diagnosis Related Groups." Kesmas: National Public Health Journal 4, no. 1 (August 1, 2009): 3. http://dx.doi.org/10.21109/kesmas.v4i1.194.

Full text
Abstract:
Di Amerika dan Australia, Kelompok Diagnosis Terkait (Diagnosis Related Group’s ) (DRGs) adalah suatu cara mengidentifikasi dan mengelompokkan pasien yang mempunyai kebutuhan dan sumber yang sama dirumah sakit berdasarkan alur perjalanan klinis (Clinical Pathway ). Penyakit yang mempunyai co morbidity atau co mortality, disebut Casemixdan mempunyai kode yang memperlihatkan derajat keparahan kelompok penyakit sehingga secara linear akan mem-pengaruhi besaran biaya perawatan. Dengan demikian, pembayaran perawatan di rumah sakit akan dilakukan berdasarkan “kesembuhan“ (cost of treatmentper diagnosis ), dan bukan berdasarkan penggunaan pelayanan medis dan non medis (fee for services). Di Indonesia sampai kini belum ada model perhi-tungan biaya untuk pembayaran perawatan mulai pasien masuk sampai sembuh dan keluar rumah sakit berdasarkan diagnosis (cost of treatment per diag-nosis). Pola pembiayaan yang digunakan di rumah sakit masih didasarkan pada fee for services. Dalam bentuk tesis, konsep Indonesia – DRG/ INA –DRG kami kembangkan di Fakultas Kesehatan Masyarakat Universitas Indonesia, mengacu pada Australian DRG.Kata kunci : INA-DRG, kelompok diagnosis terkait, alur perjalanan klinisAbstractIn America, and Australian, Diagnosis Related Groups, known as DRGs is a method to identify and classify inpatients that have the same resources within hospitals based on Clinical Pathway. It has numbering/coding system used like a menu for determining the cost. The co morbidity and/or co mortality of a di-sease is called the Casemix, where it has numbering/coding that shows the degree of severity, which the cost linearly increased. Therefore the financing is based on the in-patients’ ”recovery” (cost of treatment per diagnosis), and not based on the utility of the medical and non medical treatments ( fee for services). One of the issues arise in Indonesia’s health financing system is that it does not have the costing model for health care financing, for inpatients from ad-mission to discharge (cost of treatment per diagnosis). Therefore the financing system used is based on fee for services. Using Australian DRG as reference, the concept of Indonesia–DRG / INA–DRG is developed by the researcher with Graduate Students in the Public Health and Hospital Administration Program, Postgraduate Studies Faculty of Public Health University of Indonesia, in Thesis.Keywords : INA-DRG’s, diagnosis related groups, clinical pathway
APA, Harvard, Vancouver, ISO, and other styles
10

Elsner, H., B. B�tz, T. Magerkurth, and St R�th. "German Diagnosis Related Groups." Der Nervenarzt 74, no. 7 (July 1, 2003): 601–6. http://dx.doi.org/10.1007/s00115-003-1499-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Diagnosis related groups"

1

Ullmann, Sven-Roland. "Auswirkungen differierender Fallgewichtungen innerhalb von Diagnosis Related Groups." [S.l.] : [s.n.], 2003. http://deposit.ddb.de/cgi-bin/dokserv?idn=969843658.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kortevoß, Axel. "Krankenhausplanung unter Bedingungen der German-Diagnosis Related Groups." Diss., lmu, 2005. http://nbn-resolving.de/urn:nbn:de:bvb:19-48261.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Schum, Alexandra. "Erlösvergleich für Schockraumpatienten nach Bundespflegeverordnung, Australian Refined- Diagnosis Related Groups (AR-DRG) und German Diagnosis-Related Groups (G-DRG) einer Klinik der Maximalversorgung." Diss., lmu, 2006. http://nbn-resolving.de/urn:nbn:de:bvb:19-63169.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gao, Fei, and 高菲. "Systematic review of the impacts of diagnosis related groups and the challenges of the implementation in Mainland China." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/206937.

Full text
Abstract:
1.1 Background: Since Diagnosis Related Groups (DRGs) systems were firstly introduced in USA in 1983, they have begun to be implemented in more developed countries and some developing countries among the world during two decades. As one of the prospective payment systems, it focuses on enhancing the efficiency through reduction in the length of stays in hospitals, and improves the health care services by decreasing and controlling the unnecessary treatments. This paper reviewed the impacts of DRGs both in the countries with long period’s implementation and in China, including the above beneficial outcomes and negative influences in health care delivery. Furthermore, considering the current concerns of health care delivery in Mainland China, this paper discussed the difficulties and challenges in widely implementation over the whole country. 1.2 Methods: This study focused on the published papers in English through Pubmed, Google scholar, Google and in Chinese through CNKI. The articles in Chinese were searched from 1994. A literature search of all articles was conducted using keywords such as DRGs, impacts, efficiency, and quality both in English and in Chinese, so that relevant studies had been chosen according to the aims of the review. 1.3 Result: This review revealed the beneficial outcomes within health care delivery after the implementation of DRGs, which focused on the decrease in average length of hospital stay and the medical expenses per case. In addition, the relevant adverse outcomes had been reflected simultaneously through the studies, which were mainly indicated through the increase in emergency visits and mortality rates. The findings included both the benefits DRGs brings and negative outcomes, and the current effects of DRGs in Mainland China. 1.4 Conclusion: Diagnosis Related Groups (DRGs) system plays the different roles in different kinds of health care systems. It controls the medical expenses through less hospital activities, which can be indicated by the decreases in both the lengths of hospital stay and medical expenditures per case through the literatures. However, this system may produce the adverse outcomes within health care delivery due to insufficient, intentional, and cost-saving services. Furthermore, China has introduced this payment system since 1994, and needs to overcome the challenges through the gradual implementation process.
published_or_final_version
Public Health
Master
Master of Public Health
APA, Harvard, Vancouver, ISO, and other styles
5

Noronha, Marina Ferreira de. "Classificacao de hospitalizacoes em Ribeirao Preto: os diagnosis related groups." Sao Paulo : [s.n.], 2001. http://www.saudepublica.bvs.br/P/teses/MHdout3.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rutz, Stefan. "Die Einführung von Diagnosis Related Groups in Deutschland : Interessen - Anreize - erste Ergebnisse /." Lohmar : Eul, 2006. http://deposit.d-nb.de/cgi-bin/dokserv?id=2887385&prov=M&dok_var=1&dok_ext=htm.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nickel, Marc. "Kalkulation von Fallkosten für Diagnosis Related Groups (DRGs) in der Kardiologie." [S.l.] : [s.n.], 2004. http://deposit.ddb.de/cgi-bin/dokserv?idn=970094248.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Doege, Vanessa Martini Susanne. "Krankenhäuser auf dem Weg in den Wettbewerb : Der Implementierungsprozess der Diagnosis Related Groups /." Wiesbaden : Gabler Verlag / GWV Fachverlage GmbH, Wiesbaden, 2009. http://dx.doi.org/10.1007/978-3-8349-9979-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lossin, Astrid. "Auswirkungen der Vergütungsform auf Kosten und Qualität der Krankenhausbehandlung : diagnosis related groups und Pflegesätze im Vergleich /." Berlin : wvb, Wiss. Verl, 2006. http://www.wvberlin.de/data/inhalt/lossin.htm.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schick, Jens. "Vorbereitung der deutschen Krankenhäuser auf die G-DRG-Einführung /." Münster : Schüling, 2004. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&doc_number=012774352&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Diagnosis related groups"

1

Casas, Mercè, and Miriam M. Wiley, eds. Diagnosis Related Groups in Europe. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

F, Averill Richard, United States. Health Care Financing Administration., and Health Systems International, eds. Diagnosis Related Groups: Definitions manual. 3rd ed. [Washington, D.C: Health Care Financing Administration, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hirsh, Harold L. Diagnosis related groups: Course manual. [Washington, D.C.] (1120 20th St., NW, Washington 20036): Federal Publications, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mary, Paquette, and Mirch Mary, eds. Nursing diagnosis care plans for diagnosis-related groups. Venice, Calif: General Medical Publishers, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Neal, Margo Creighton. Nursing diagnosis care plans for diagnosis-related groups. Boston: Jones & Bartlett, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

F, Averill Richard, United States. Health Care Financing Administration., and 3M Health Information Systems, eds. DRGS, diagnosis related groups, definitions manual. 9th ed. [Washington, D.C.]: 3M Health Information Systems, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Fred, Paccaud, Schenker Luc, and Institut suisse de la santé publique et des hôpitaux., eds. D.R.G. (Diagnosis related groups): Perspectives d'utilisation. Lyon: Alexandre Lacassagne, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

F, Averill Richard, United States. Health Care Financing Administration., and 3M Health Information Systems, eds. DRGs: Diagnosis related groups definitions manual. [Washington, D.C.]: 3M Health Information Systems, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

B, Fetter Robert, Brand Donald A, and Gamache Dianne, eds. DRGs: Their design and development. Ann Arbor, Mich: Health Administration Press, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nancy, Lemrow, and United States. Agency for Health Care Policy and Research. Division of Provider Studies, eds. The 50 most frequent diagnosis-related groups (DRGs), diagnoses, and procedures: Statistics by hospital size and location. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Diagnosis related groups"

1

Iswanto, A. Heri. "Diagnosis-Related Groups." In Hospital Economics, 131–40. Boca Raton : Taylor & Francis, 2018. | “A CRC title, part of the Taylor & Francis imprint, a member of the Taylor & Francis Group, the academic division of T&F Informa plc.”: Productivity Press, 2018. http://dx.doi.org/10.4324/9781351172523-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wiedemann, Manfred. "DRG: Diagnosis Related Groups – Fallpauschalen." In Die Medizin verkauft ihre Seele, 49–63. Berlin, Heidelberg: Springer Berlin Heidelberg, 2020. http://dx.doi.org/10.1007/978-3-662-60956-9_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

France, Francis H. Roger. "Hospital Information Systems in Europe: Trends Towards Uniformity in Patient Record Summaries." In Diagnosis Related Groups in Europe, 3–16. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vertrees, James C., and Kenneth G. Manton. "Using Case Mix for Resource Allocation." In Diagnosis Related Groups in Europe, 155–72. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bentes, Margarida E., Joao A. Urbano, Maria Do Carmo Carvalho, and Maria S. Tranquada. "Using DRGs to Fund Hospitals in Portugal: An Evaluation of the Experience." In Diagnosis Related Groups in Europe, 173–92. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ibern, Pere, James C. Vertrees, Kenneth G. Manton, and Max A. Woodbury. "Hospital Groups and Case-Mix Measurement for Resource Allocation and Payment." In Diagnosis Related Groups in Europe, 193–207. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rodrigues, Jean-Marie. "DRGs: Origin and Dissemination Throughout Europe." In Diagnosis Related Groups in Europe, 17–29. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

McGuire, Thomas E. "DRG Evolution." In Diagnosis Related Groups in Europe, 30–45. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sanderson, Hugh F. "DRGs: How Well Do They Define Hospital Products in Europe?" In Diagnosis Related Groups in Europe, 46–60. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Casas, Mercè, and Rosa Tomàs. "Producing DRG Statistics at the European Level: Lessons from the EURODRG Project." In Diagnosis Related Groups in Europe, 63–80. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78472-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Diagnosis related groups"

1

Santana-Velasquez, Angelower, M. John Freddy Duitama, and Julian D. Arias-Londono. "Classification of Diagnosis-Related Groups using Computational Intelligence Techniques." In 2020 IEEE Colombian Conference on Applications of Computational Intelligence (ColCACI). IEEE, 2020. http://dx.doi.org/10.1109/colcaci50549.2020.9247889.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Socher, Karen, Douglas Nunes, Deborah Lopes, Artur Coutinho, Daniele Faria, Paula Squarzoni, Geraldo Busatto Filho, Carlos Buchpighel, Ricardo Nitrini,, and Sonia Brucki. "VISUAL MEDIAL TEMPORAL ATROPHY SCALES IN CLINICIAN PRACTICE." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda102.

Full text
Abstract:
Background: Visual atrophy scales from the medial temporal region are auxiliary biomarker methods in Alzheimer’s Disease(AD).They may correlated with progression from preclinical to clinical AD. Objective: We aimed to compare medial temporal lobe atrophy (MTA) and entorhinal cortex atrophy (ERICA) scales for magnetic resonance image as a useful tool for probable AD diagnosis and evaluate their accuracy, sensitivity and specificity, regarding clinical diagnosis and 11C-PIB-PET. Methods: 2 neurologists blinded to diagnosis classified 113 adults (over 65y) through MTA and ERICA scales and correlated with sociodemographic data, amyloid brain cortical burden through the 11C-PIB-PET and clinical cognitive status, divided into 30 cognitive unimpaired (CU) individuals, 52 MCI and 31 dementia compatible with AD (DCAD). Results: Inter-rater reliability of these atrophy scales was excellent (0.8- 1) by Cohen analysis. CU group had significantly lower MTA scores (median value 0) than ERICA (median value 1)for both hemispheres. 11C-PIB-PET was positive in 45% of the whole sample. In MCI and DCAD groups, ERICA depicted greater sensitivity and MTA greater specificity. Accuracy was under 70% for both scores in all clinical groups. Conclusion: Our study achieved a moderate sensitivity for ERICA score and could be a better screening tool for DCAD or MCI than MTA score. But, none of them could be considered a useful biomarker in preclinical AD.
APA, Harvard, Vancouver, ISO, and other styles
3

Queiroz, Andrei Alves de, Gustavo Machado Badan, Marilucia Batina Fernandes Moreira, and Amanda Neves Machado. "IMPACT OF COVID-19 ON BREAST CANCER TUMOR SIZE AT DIAGNOSIS." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1006.

Full text
Abstract:
Introduction: In 2020, COVID-19 affected the whole world, determining a pandemic situation, with recommendations for social isolation and lockdown. In the state of São Paulo, the shutdown of non-essential services was determined on March 22, 2020. Medical appointments and routine imaging exams were postponedand little is known about the impact on screening delay and the diagnosis of neoplasms. Considering that survival and cure of breast cancer are directly related to an early diagnosis, the size of these malignant tumors can be used in researching the delay in breast cancer diagnoses. Objectives: To evaluate the impact of the pandemic on the size of breast cancer in histological diagnosis, as well as on the number of diagnostic procedures performed at our hospital. Methods: Through a retrospective, analytical and crosssectional study, we analyzed data regarding tumors with histological results of malignancy of core needle breast biopsies guided by ultrasound performed at a private hospital in São Paulo between January 1, 2019 and December 31, 2020. The mean tumor sizes were compared to identify differences between prepandemic and pandemic periods. The prepandemic period (PRE) was established between January 1, 2019 and March 31, 2020, and the pandemic period (PAN) was considered from April 1 to December 31, 2020. Based on the sample size, this study has the power of 80% to detect a variation of 1 cm in the mean tumor size. Results: A total of 493 core needle biopsies were identified in 443 patients. A total of 103 (20.1%) biopsies in 94 patients were malignant. In the PAN group, 36 cases of cancer were diagnosed (4 cases/month), while the PRE group diagnosed 67 cases (4.5 cases/month). The mean size of PRE tumors was 1.66 cm, while in PAN tumors it was 2.21, showing a difference of 0.55 cm without statistical significance (95%CI 0.12–1.21; p=0.12). When considering staging (TNM – Tumor, Node, Metastases), the stages T1, T2 and T3 had no significant difference among the groups (p=0.12). The age at diagnosis of malignant lesions ranged from 30 to 82 years in the PRE period, and from 34 to 85 years in the PAN period. The mean age of patients with malignant lesions diagnosed in PAN was higher than PRE, without statistical significance (59.2 vs 56.0; p=0.30). Despite the fewer biopsies performed in both periods, (p <0.001), there was no statistical difference in the number of biopsies with malignant results (p=0.18), since there were proportionally more diagnoses of malignancy in the PAN period (28.6% vs. 18.3%; RR 1.14; 95%CI 1.01–1.29; p=0.02). Conclusions: Although the pandemic affected breast cancer screening, no statistically significant increase in the mean size of tumors has been diagnosed in this service so far.
APA, Harvard, Vancouver, ISO, and other styles
4

Formoso, Carolina Rodrigue, Raphael Machado Castilhos, Wyllians Vendramini Borelli, Matheus Zschornack Strelow, and Marcia Fagundes Chaves. "ANTICHOLINERGIC BURDEN IN DEMENTIA." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda031.

Full text
Abstract:
Background: The anticholinergic burden is associated with a greater risk of functional/ cognitive decline and morbidity/mortality. Objectives: Our aim was to quantify the anticholinergic burden in the first visit in our dementia tertiary outpatient clinic. Methods: We performed a retrospective analysis of all first visit medical records of patients referred from primary health care to the outpatient dementia clinic of a tertiary hospital in Porto Alegre with a final diagnosis of dementia or Mild Cognitive Impairment (MCI) between 2014-2019. We evaluated all medications in use and we calculated a final score using Brazilian Anticholinergic Activity Drug (BAAD) score. This scale classified drugs according to its central anticholinergic activity from 1 to 3, with higher values indicating greater activity. The final score is the sum of the score for each drug. We divided the sample in two groups (score=0 and ⩾ 1) and performed a logist regression using age, sex, dementia diagnosis and MMSE as covariates. Results: We identified 199 final diagnoses of dementia (mostly Alzheimer’s Disease (AD) [45.2%]) and 39 of MCI. Most patients with dementia (76.4%) and MCI (74.3%) had at least a BAAD score = 1. Median (IQI) BAAD score was higher in VD, 4 (1.0-6.5). In the regression analysis, BAAD score was associated with MMSE, controlling for covariates. Conclusions: In our sample, the anticholinergic burden was high and correlated with dementia severity.
APA, Harvard, Vancouver, ISO, and other styles
5

Vieira, René Aloisio da Costa, William Eduardo PIrola, Eliane Marçon Barrose, Ricardo Ribeiro Gama, and Valiana Alves Teodoro. "Periodontal disease as a risk factor for breast cancer: A case–control study based on a comprehensive clinical periodontal evaluation." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1020.

Full text
Abstract:
Objective: The objective of this study was to evaluate the risk association related to periodontal disease and breast cancer performing a prospective case-matched control study. Methodology: It was a prospective controlled study, performed to evaluate the possible association with Parkinson’s disease (PD) and breast cancer. The Institutional Board for Ethics in Research approved the study (CAAE: 08989019.9.0000.5437). This case–control was designed as a 1:1 propensity study that included 64 volunteers with breast cancer before treatment and 64 women volunteers with no cancer. The cases and matched controls were recruited from the Barretos Cancer Hospital. For matching, cases and controls were matched by age, income of families, education, and smoking status (considered former smoker or current smoker). All of the patients interviewed participated voluntarily and signed an informed consent form. For both groups, women, over 40 years old, have at least 17 teeth, no history of familial breast cancer, no prior cancer, and no history of breast cancer in the family. For the case group, patients with breast cancer diagnosis and who knew about their breast cancer diagnosis were included. For the control group, patients without cancer diagnosis and normal mammographic examination, or if altered, the final finding, showing the absence of neoplasm or risk for breast cancer, were included. For data collection of periodontal parameters, the instrument available in the online version through the website Periodontalchart-online.com/pt developed by the University of Bern, Switzerland, was used. Periodontal indices were measured with the aid of a model periodontal probe from the University of North Carolina. PD indices were considered according to the parameters described by the American Academy of Periodontology Results: A total of 128 research participants were included in the study, in two groups, 64 participants without cancer (control group) and 64 patients with breast cancer (case group). The groups were similar related to age, income, education, and smoking. Evaluating oral health parameters, the groups were different. Case groups were associated with better related to the frequency of tooth brushing per day and daily mouthwash uses but worse oral parameters evaluated by mean plaque index, blending on probing, and periodontal probing depth. PD was significantly associated with BC for all case definitions (p <0.001). In the multivariable analysis, periodontitis was significantly associated with breast cancer in a sample of severe and moderate periodontitis. Women diagnosed with moderate periodontitis have four times higher odds of having breast cancer than women without periodontitis. Women with severe periodontitis have 10 times higher odds of having breast cancer. Conclusion: There is a possible increased risk of breast cancer diagnosis in women with active PD when compared with women without PD. Researchers have developed studies with the referred objective as an alternative to carry out the prevention of pathologies through an important oral health action. New studies need to be carried out to corroborate the findings to formulate public health policies.
APA, Harvard, Vancouver, ISO, and other styles
6

Cecato, Juliana, and Livia Galeote. "SENILITY AND COGNITIVE PERFORMANCE: ANALYSIS OF WECHSLER SCALE IN ELDERLY WITH MAJOR NEUROCOGNITIVE DISORDER." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda074.

Full text
Abstract:
Background: CHC theory is a hierarchical model of intelligence, organized through cognitive skills and dividing the construct into crystallized and fluid. Objective: To describe the correlation among crystallized and fluid abilities in healthy people diagnosed with dementia. Methods: 45 subjects with 50 to 89 years old and at least 1 year of schooling. They were submitted to a detailed clinical interview and, later, to a neuropsychological evaluation. RAVLT, Wechsler Intelligence Scale (WAIS-III or WASI) and FDT were applied. Sample was divided into 2 groups: healthy elderly (without cognitive and functional decline) and those diagnosed with dementia (GE). The diagnosis of dementia was based on the DSM-5. Results: RAVLT and the Wechsler Scale differentiated HE from DG (p <0.0001). FDT did not show a statistically significant difference in the Counting, Reading and Inhibition items, showing that tasks involve time were not able to differentiate healthy individuals from DG. To compare the performance IQ it is evident that the performance in fluid skills is less effective, when compared to the crystallized items (IQ verbal), in differentiating healthy subjects from dementia. Conclusion: Tasks involving learning, delayed recall memory and recognition, that is, crystallized tasks, are more effective in differentiating dementia when compared to fluid tasks (processing speed).
APA, Harvard, Vancouver, ISO, and other styles
7

Maffioletti, Virgínia Lúcia, Maria Alice Baptista, Felipe Silva, Valeska Marinho, Maria Cavalcanti, and Marcia Cristina Dourado. "DAY CENTER FOR PEOPLE WITH DEMENTIA: A RETROSPECTIVE STUDY ON ADHERENCE." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda032.

Full text
Abstract:
Background: Evidence shows that day centers (DC) are an effective technology to support people with dementia (PwD) and their family caregivers (FC). Objective: To assess the mediators of adherence to treatment for PwD attended in DC. Methods: Retrospective study with a sample of 143 PwD who attended a DC between May 1998 and March 2020. The sample was divided into 4 groups by period of attendance. A descriptive and comparative analysis of sociodemographic factors and disease severity (CDR) at admission was performed. Results: The mean usage rate was 43.36 months. Most PwD started treatment at CDR2, had more than 8 years of schooling and were cared for by their spouses or children. Most FC had more than 8 years of schooling. The main reasons for discharge were worsening and death, and only 2% were institutionalized. There was no difference between groups in diagnosis, gender and PwD and FC schooling. From group that attended the DC for more than 36 months, 60% were married, 60% were cared for by their spouses, 41% were cared for by their children, and most had more than 8 years of schooling. Conclusion: The early start of treatment, being cared for by the spouse or children were mediators of treatment adherence. Education appears as a mediator in the search for treatment. The longevity of treatment and the low institutionalization rate suggest that the DC is a support device for PwD and their FC.
APA, Harvard, Vancouver, ISO, and other styles
8

Machado, Samira Juliana de Moraes, Renato Cagnacci Neto, Marina Sonagli, Hirofumi Iyeyasu, and Fabiana Baroni Alves Makdissi. "ANALYTICAL CROSS-SECTIONAL STUDY TO ASSESS THE IMPACT OF THE COVID-19 PANDEMIC ON THE STAGING OF BREAST CANCER PATIENTS." In XXIV Congresso Brasileiro de Mastologia. Mastology, 2022. http://dx.doi.org/10.29289/259453942022v32s1003.

Full text
Abstract:
Introduction: We are currently living in a state of pandemic by COVID-19, whose virus has high transmissibility and potential lethality. The World Health Organization recommended social isolation, and the Brazilian National Cancer Institute, following this guidance, proposed that the oncological treatment of low-to-moderate aggressive tumors be postponed, including breast cancer. In Brazil, the lockdown was a strategy to reduce the potential impact of the pandemic on health services; consequently, asymptomatic patients postponed their imaging tests this year. Considering this abrupt change in access to health care and in the routine of cancer screening, we theorize that the COVID-19 pandemic may have had a negative impact on diagnosis, treatment, and survival in breast cancer patients. Objective: The aim of this study was to analyze the staging at diagnosis of patients with breast cancer, before and during the pandemic, and to calculate if there was a statistical difference comparing the two groups studied. A secondary objective was to describe clinical and demographic characteristics. Methods: A single-center, cross-sectional analytical study with 1219 patients diagnosed with breast cancer (CID C50 or D05) treated at the Mastology Department of the AC Camargo Cancer Center from March 2019 to February 2021. The following epidemiological variables were evaluated: age at years at diagnosis, clinical staging at diagnosis (TNM 8th edition©), presence of comorbidities (risk group for severe COVID-19), family history of cancer, symptoms at diagnosis, and provenance. Descriptive variables and data analysis was performed using Pearson’s χ2 test or Fisher’s exact test. Results: In this study, 1002 patients were included, divided into two groups: prepandemic (574) and pandemic (428). Both groups had similar demographic and clinical characteristics. There was an increase in the frequency of symptomatic patients in the pandemic period 199 (46.5%) versus nonpandemic period 213 (37.1%) (p=0.003). Anatomical and clinical staging were similar between the groups, with no statistically significant difference. When analyzing the anatomical staging, comparing the prepandemic versus pandemic groups, we observed a higher frequency of tumors: T1 [262 (45.6%) vs. 170 (39.8%), p=0.376]; N0 [398 (69.2%) vs. 288 (67.4%), p=0.194]; M0 [552 (96.0%) vs. 415 (97.2%), p=0.614]. Regarding clinical staging, early malignant tumors (EC Tis, Ia–IIIa) were more frequent, corresponding to 521 (90.8%) prepandemic versus 390 (91.1%) pandemic (p=0.766). Conclusion: There was no significant variation between the groups in terms of staging at diagnosis, but more patients with symptoms related to breast cancer sought cancer care.
APA, Harvard, Vancouver, ISO, and other styles
9

Ciarlini, Bruna, Flávia E. Silva, Álissa Moura, Emmanuelle Sobreira, Roberto Paiva, Norberto Frota, and Fernanda Carvalho. "ACCUMBENS AREA MAY PLAY A ROLE IN FACIAL RECOGNITION OF EMOTIONS IN A LOW-EDUCATED POPULATION WITH MILD ALZHEIMER’S DISEASE." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda064.

Full text
Abstract:
Background: There is no consensus on how recognition of universal facial emotions can be affected in low-educated individuals with Alzheimer’s Disease (AD). Objective: To assess the performance of Facial Recognition of Emotions Test (FERT) and to correlate with patterns of cortical atrophy measured through Voxel-Based Morphometry (VBM) in low-educated individuals with mild AD dementia compared to cognitively healthy people. Methods: Retrospective cohort of 24 adult volunteers with 4 years of schooling or less were included. Among them, 13 participants had a diagnosis of mild AD. Data obtained by VBM and FERT result were correlated. Results: AD group had a worse performance in the total FERT score (p <0.001). There was a statistically significant difference in the recognition of surprise, disgust and neutrality (p <0.001). A more intense and consistent correlation was observed between the volume of the Accumbens Area (AA) and FERT performance in the total group (r=0.817 and p <0.05). This correlation remained significant for emotion “disgust” only in the AD group (r=0.769 and p <0.05). Conclusion: We found a significant difference in the recognition of surprise, disgust and neutral emotions between groups. The brain region that was most associated with these emotions was the AA, with greater consistency in the difficulty in recognizing the emotion of disgust, in the AD.
APA, Harvard, Vancouver, ISO, and other styles
10

Assis, Amilcar Alves, Mauro Passos, Rodrigo Kouzak, Karoline Evangelista, and Natasha Caldas. "BREAST CANCER IN YOUNG PATIENTS: PROGNOSTIC AND PROFILE EPIDEMIOLOGICAL ANALYSIS IN A TERTIARY HOSPITAL." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2093.

Full text
Abstract:
Breast cancer is the second most prevalent and first in mortality in Brazilian women. Its incidence has increased in recent years in all age groups. According to the Instituto Nacional do Câncer in 2019, 59,700 new cases of breast cancer are expected, with an estimated risk of 56.33 cases per 100 women. The diagnosis of breast cancer is more frequent in women after 50 years of age; it is estimated that only 25% of all cases occur in women below the age of 50 years; however, there was a literature consensus that tumors in this young age group have a worse prognosis, both because they are biologically more aggressive and because of affect women outside the screening age group in Brazil; thus, the rate of locally advanced disease at diagnosis in this age group is considerably higher. It is suggested that early onset breast cancer is related to different etiological factors, histopathological aspects, and clinical outcomes, as compared to postmenopausal breast cancer. Thus, age becomes an important prognostic factor. Since breast cancer is a curable pathology, the type of therapeutic approach also varies, with proposed treatment tends to be more aggressive. With the advent and increasing availability of genetic tests, predisposition of breast cancer has increased the number of indications for prophylactic mastectomies, especially in younger age groups or notably in patients with known pathological mutations in BRCA1 and BRCA2 genes. However, the literature is still controversial regarding its impact on overall survival. Breast cancer diagnosed before the age of 50 years is a behavioral disease, with prognosis and approach very different from that diagnosed in postmenopausal women. Therefore, it is important to know the profile of these patients to provide optimal treatment and achieve the best outcomes.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Diagnosis related groups"

1

WANG, Xuesong, Xuliang SHI, Jing LV, Juncha ZHANG, Yongli HUO, Guang ZUO, Guangtong LU, Cunzhi LIU, and Yanfen SHE. Acupuncture and Related Therapies for anxiety and depression in Diarrhoea-Predominant Irritable Bowel Syndrome(IBS-D): A Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0162.

Full text
Abstract:
Review question / Objective: Acupuncture-related therapies are effective Diarrhoea-Predominant Irritable Bowel Syndrome(IBS-D), therefore, our aim was to evaluate and rank the effect of different acupuncture-related therapies for the anxiety-depression status of IBS-D patients. Eligibility criteria: The published randomized controlled trials (RCTs) of acupuncture-related therapies for the treatment of IBS-D, regardless of age and sex. Clear diagnostic criteria were required to confirm the diagnosis of IBS-D, Such as Rome I, Rome II, Rome III, Rome IV, and Chinese expert consensus. Interventions in the treatment group included various types of acupuncture-related therapies, including simple acupuncture (ACU), electroacupuncture (EA), warm acupuncture (WA), moxibustion (MOX), or a combination of acupuncture and drugs; the control group is anti-diarrheal or anti-spasmodic western medicine, or placebo, or comparison between various acupuncture-related therapies. The results of the report are required to include at least one of the following outcome indicators: (1) primary outcome: Hamilton anxiety rating scale( HAMA), hamilton depression rating scale(HAMD), self-rating anxiety scale (SAS), self-rating depression scale(SDS), secondary outcome: Response rate. The language of the publication was limited to Chinese or English.
APA, Harvard, Vancouver, ISO, and other styles
2

Gandini, Camilla, Andrea Monje Silva, and Pablo Guerrero. Gender and Transport in Haiti: Gender Diagnostic and Gender Action Plan. Edited by Amanda Beaujon Marin. Inter-American Development Bank, February 2021. http://dx.doi.org/10.18235/0003069.

Full text
Abstract:
This technical note encompasses Haiti's gender assessment, evaluates the success of gender specific actions implemented between 2011-2017, and presents a Gender and Transport Action Plan (GAP). The GAPs main aim is to guide investments in Haiti's transport sector in conceptualizing and designing gender-sensitive transport projects. By proposing specific gender actions and outcomes, the GAP establishes a clear path to integrate a gender dimension into operations design, implementation and, monitoring and evaluation. The GAP presents an overall plan to support the development of Haitian women. However, it focuses in the needs of women as transport services users and devotes specific attention to two female sub-groups, comprised by Haitian women engaged in informal trade of local and regional products. These women are known as Madan Sara (MS), and local female mango producers and traders (MPT). The decision of focusing on MS is related to their vital role in the Haitian local labor market and the peculiarity of their work, which has specific transport needs. Understanding and addressing these female groups transport constrains could strategically improve the outcomes of upcoming transport investments and bring more benefits to its beneficiaries.
APA, Harvard, Vancouver, ISO, and other styles
3

Neymark, J., R. Judkoff, I. Beausoleil-Morrison, A. Ben-Nakhi, M. Crowley, M. Deru, R. Henninger, et al. International Energy Agency Building Energy Simulation Test and Diagnostic Method (IEA BESTEST): In-Depth Diagnostic Cases for Ground Coupled Heat Transfer Related to Slab-on-Grade Construction. Office of Scientific and Technical Information (OSTI), September 2008. http://dx.doi.org/10.2172/937333.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wu, Xiaoqi, Jisen Zhao, Maoxia Fan, and Dongo Guo. Quality of Evidence Supporting the Effects of Xinmailong injection in Heart Failure: An Overview of Systematic Reviews and Meta-Analyses. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2022. http://dx.doi.org/10.37766/inplasy2022.10.0023.

Full text
Abstract:
Review question / Objective: 2.1.1 type of research SRs/MAs of RCT (randomized controlled trial) of Xinmailong injection for the treatment of heart failure. 2.1.2 Subject investigated All included patients met internationally recognized diagnostic criteria for heart failure.There are no limitations on age, gender, ethnicity, time of onset, source of cases and language of publication. 2.1.3 Type of Intervention The control group was treated with conventional basic Western medicine recommended by the guidelines related to heart failure[1, 11], including antiplatelet drugs, anticoagulants, vasodilators, beta-blockers,ACEI (angiotensin-converting enzyme inhibitors), lipid-lowering drugs, and diuretic agents. and other drug treatment. The intervention group was given Xinmailong injection on the basis of the control group.
APA, Harvard, Vancouver, ISO, and other styles
5

Jangir, Hemlata, Aparna Ningombam, Arulselvi Subramanian, and Subodh Kumar. Traumatic Jejunal Mesenteric Pseudocyst in the Vicinity of Blunt Abdominal Trauma with a Brief Review of Literature. Science Repository, January 2023. http://dx.doi.org/10.31487/j.ajscr.2022.04.04.

Full text
Abstract:
Mesenteric pseudocyst (MP) is a rare heterogeneous group of intra-abdominal benign cystic lesions with different etiopathogenesis and clinically silent behaviours. These lesions are introduced as one of the entities based on the histological features of thick fibrous cyst walls, barren of the epithelial lining. Often, they present as expanding abdominal masses or are diagnosed incidentally in conventional radiological studies, exploratory laparotomies, or with symptoms of complications such as infection, torsion, or rupture. Surgical removal of the cyst, with or without resection of the affected intestinal segment, is the treatment of choice. Depending upon the size and location of the lesion and related complications, it can be managed by open surgical procedures or laparoscopic approach. Only a handful of 7 cases of traumatic mesenteric cysts have been reported yet in the vicinity of blunt abdominal trauma. We report a rare incidentally detected case of mesenteric pseudocyst (traumatic) in a male of early 20s with a history of blunt abdominal trauma 13 months back and for which serial abdominal exploratory laparotomies were performed. A brief review of the literature is provided, conforming to the rarity of the case. This case highlights the role of histomorphology in diagnosing a benign cystic entity with accuracy, that could be misdiagnosed as infectious granulomatous lesion.
APA, Harvard, Vancouver, ISO, and other styles
6

Rans, Richard. PR-352-16603-Z03 Multi-Vendor USM Test and Calibration Database with Common Diagnostics. Chantilly, Virginia: Pipeline Research Council International, Inc. (PRCI), March 2020. http://dx.doi.org/10.55274/r0011657.

Full text
Abstract:
Data collection protocols and a common database have been developed to ensure complete and consistent collection of USM calibration data, logs files and documentation of test piping layout. By using an Excel input table spreadsheet, with instructions on how to organize the collected data, users can easily input data from multiple types of ultrasonic meters. The database retains the original calibration and log file data and processes the test results into standardized velocity and speed of sound reports. This organization supports reporting the original meter specific log file data and diagnostics as well as common velocity/speed of sound analysis of the test results. As the database of test results grows over time, additional comparative and what if analysis of the test results will provide insight into ultrasonic meter measurement capabilities. By adding common diagnostic analysis to the database and using the results of existing PRCI installation effect tests, the quantitative high/median RSS risk associated with changes in piping has been determined. This quantitative risk estimate can be applied to controlling the changes between calibration and operating conditions. This zip file contains the related report, the corresponding database with data, installation instructions, and the corresponding reporting tools.
APA, Harvard, Vancouver, ISO, and other styles
7

Newman-Toker, David E., Susan M. Peterson, Shervin Badihian, Ahmed Hassoon, Najlla Nassery, Donna Parizadeh, Lisa M. Wilson, et al. Diagnostic Errors in the Emergency Department: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), December 2022. http://dx.doi.org/10.23970/ahrqepccer258.

Full text
Abstract:
Objectives. Diagnostic errors are a known patient safety concern across all clinical settings, including the emergency department (ED). We conducted a systematic review to determine the most frequent diseases and clinical presentations associated with diagnostic errors (and resulting harms) in the ED, measure error and harm frequency, as well as assess causal factors. Methods. We searched PubMed®, Cumulative Index to Nursing and Allied Health Literature (CINAHL®), and Embase® from January 2000 through September 2021. We included research studies and targeted grey literature reporting diagnostic errors or misdiagnosis-related harms in EDs in the United States or other developed countries with ED care deemed comparable by a technical expert panel. We applied standard definitions for diagnostic errors, misdiagnosis-related harms (adverse events), and serious harms (permanent disability or death). Preventability was determined by original study authors or differences in harms across groups. Two reviewers independently screened search results for eligibility; serially extracted data regarding common diseases, error/harm rates, and causes/risk factors; and independently assessed risk of bias of included studies. We synthesized results for each question and extrapolated U.S. estimates. We present 95 percent confidence intervals (CIs) or plausible range (PR) bounds, as appropriate. Results. We identified 19,127 citations and included 279 studies. The top 15 clinical conditions associated with serious misdiagnosis-related harms (accounting for 68% [95% CI 66 to 71] of serious harms) were (1) stroke, (2) myocardial infarction, (3) aortic aneurysm and dissection, (4) spinal cord compression and injury, (5) venous thromboembolism, (6/7 – tie) meningitis and encephalitis, (6/7 – tie) sepsis, (8) lung cancer, (9) traumatic brain injury and traumatic intracranial hemorrhage, (10) arterial thromboembolism, (11) spinal and intracranial abscess, (12) cardiac arrhythmia, (13) pneumonia, (14) gastrointestinal perforation and rupture, and (15) intestinal obstruction. Average disease-specific error rates ranged from 1.5 percent (myocardial infarction) to 56 percent (spinal abscess), with additional variation by clinical presentation (e.g., missed stroke average 17%, but 4% for weakness and 40% for dizziness/vertigo). There was also wide, superimposed variation by hospital (e.g., missed myocardial infarction 0% to 29% across hospitals within a single study). An estimated 5.7 percent (95% CI 4.4 to 7.1) of all ED visits had at least one diagnostic error. Estimated preventable adverse event rates were as follows: any harm severity (2.0%, 95% CI 1.0 to 3.6), any serious harms (0.3%, PR 0.1 to 0.7), and deaths (0.2%, PR 0.1 to 0.4). While most disease-specific error rates derived from mainly U.S.-based studies, overall error and harm rates were derived from three prospective studies conducted outside the United States (in Canada, Spain, and Switzerland, with combined n=1,758). If overall rates are generalizable to all U.S. ED visits (130 million, 95% CI 116 to 144), this would translate to 7.4 million (PR 5.1 to 10.2) ED diagnostic errors annually; 2.6 million (PR 1.1 to 5.2) diagnostic adverse events with preventable harms; and 371,000 (PR 142,000 to 909,000) serious misdiagnosis-related harms, including more than 100,000 permanent, high-severity disabilities and 250,000 deaths. Although errors were often multifactorial, 89 percent (95% CI 88 to 90) of diagnostic error malpractice claims involved failures of clinical decision-making or judgment, regardless of the underlying disease present. Key process failures were errors in diagnostic assessment, test ordering, and test interpretation. Most often these were attributed to inadequate knowledge, skills, or reasoning, particularly in “atypical” or otherwise subtle case presentations. Limitations included use of malpractice claims and incident reports for distribution of diseases leading to serious harms, reliance on a small number of non-U.S. studies for overall (disease-agnostic) diagnostic error and harm rates, and methodologic variability across studies in measuring disease-specific rates, determining preventability, and assessing causal factors. Conclusions. Although estimated ED error rates are low (and comparable to those found in other clinical settings), the number of patients potentially impacted is large. Not all diagnostic errors or harms are preventable, but wide variability in diagnostic error rates across diseases, symptoms, and hospitals suggests improvement is possible. With 130 million U.S. ED visits, estimated rates for diagnostic error (5.7%), misdiagnosis-related harms (2.0%), and serious misdiagnosis-related harms (0.3%) could translate to more than 7 million errors, 2.5 million harms, and 350,000 patients suffering potentially preventable permanent disability or death. Over two-thirds of serious harms are attributable to just 15 diseases and linked to cognitive errors, particularly in cases with “atypical” manifestations. Scalable solutions to enhance bedside diagnostic processes are needed, and these should target the most commonly misdiagnosed clinical presentations of key diseases causing serious harms. New studies should confirm overall rates are representative of current U.S.-based ED practice and focus on identified evidence gaps (errors among common diseases with lower-severity harms, pediatric ED errors and harms, dynamic systems factors such as overcrowding, and false positives). Policy changes to consider based on this review include: (1) standardizing measurement and research results reporting to maximize comparability of measures of diagnostic error and misdiagnosis-related harms; (2) creating a National Diagnostic Performance Dashboard to track performance; and (3) using multiple policy levers (e.g., research funding, public accountability, payment reforms) to facilitate the rapid development and deployment of solutions to address this critically important patient safety concern.
APA, Harvard, Vancouver, ISO, and other styles
8

Wang, Ying yuan, Zechang Chen, Luxin Zhang, Shuangyi Chen, Zhuomiao Ye, Tingting Xu, and Yingying Zhang c. A systematic review and network meta-analysis: Role of SNPs in predicting breast carcinoma risk. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0092.

Full text
Abstract:
Review question / Objective: P: Breast cancer patient; I: Single nucleotide polymorphisms associated with breast cancer risk; C: Healthy person; O: By comparing the proportion of SNP mutations in the tumor group and the control group, the effect of BREAST cancer risk-related SNP was investigated; S: Case-control study. Condition being studied: Breast cancer (BC) is one of the most common cancers among women, and its morbidity and mortality have continued to increase worldwide in recent years, reflecting the strong invasiveness and metastasis characteristics of this cancer. BC is a complex disease that involves a sequence of genetic, epigenetic, and phenotypic changes. Polymorphisms of genes involved in multiple biological pathways have been identified as potential risks of BC. These genetic polymorphisms further lead to differences in disease susceptibility and severity among individuals. The development of accurate molecular diagnoses and biological indicators of prognosis are crucial for individualized and precise treatment of BC patients.
APA, Harvard, Vancouver, ISO, and other styles
9

Henley, Megan, Lindie Hill, Sydney Inman, Molly King, Sam Lopez, and Carley Mahaffey. Long-Term Outcomes in Children with Acute Flaccid Myelitis. University of Tennessee Health Science Center, May 2021. http://dx.doi.org/10.21007/chp.mot2.2021.0007.

Full text
Abstract:
The purpose of our critically appraised topic is to combine the best evidence regarding the long-term outcomes in children with acute flaccid myelitis (AFM) regarding posture and movement, gross and fine motor control, and activities of daily living (ADL) performance. The final portfolio contains eight articles. The study designs of these articles include a retrospective cohort study, two retrospective non-randomized studies without a control group, a retrospective review, a nationwide follow-up questionnaire analysis study, a case report, a case series, and a multiple quantitative case study. All studies related directly to our evidence-based PICO question and were used to determine the best evidence of the long-term outcomes in children with AFM. Overall, our findings showed that functional improvements were seen in most i ndividuals, however, this varied from complete to incomplete recovery along with some persistent motor and functional deficits. Every case is different depending on when they were diagnosed, and how quickly they were able to implement a rehabilitation program into their everyday routine.
APA, Harvard, Vancouver, ISO, and other styles
10

Rans, Richard. PR-352-16603-Z02 Multi-Vendor USM Test and Calibration Database. Chantilly, Virginia: Pipeline Research Council International, Inc. (PRCI), March 2020. http://dx.doi.org/10.55274/r0011656.

Full text
Abstract:
Data collection protocols and a common database have been developed to ensure complete and consistent collection of ultrasonic meter (USM) calibration data, logs files and documentation of test piping layout. By using an Excel input table spreadsheet, with instructions on how to organize the collected data, users can easily input data from multiple types of ultrasonic meters. The database retains the original calibration and log file data and processes the test results into standardized velocity and speed of sound reports. This organization supports reporting the original meter specific log file data and diagnostics as well as common velocity/speed of sound analysis of the test results. As the database of test results grows over time, additional comparative and what if analysis of the test results will provide insight into ultrasonic meter measurement capabilities. This report describes the database design and data processing data flow. It is targeted at IT professionals who will install, operate and maintain the database. This report has a related webinar.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Diagnosis related groups' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography